Filter
939
Filtered Results: 939
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
79
New Publications
285
Language
Document type
No document type
483
Studies & Reports
170
Guidelines
141
Manuals
57
Strategic & Response Plan
52
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
South Africa
24
Global
23
Liberia
21
Ghana
20
Nigeria
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Malawi
15
Bangladesh
15
Nepal
14
Western and Central Europe
14
Namibia
13
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Latin America and the Carribbean
4
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
415
Clinical Guidelines
58
Key Resources
36
Public Health
35
Pharmacy & Technologies
28
Women & Child Health
23
Capacity Building
3
Toolboxes
AMR
123
Pharmacy
118
COVID-19
54
HIV
39
TB
39
Rapid Response
34
Mental Health
31
Global Health Education
20
Planetary Health
19
Caregiver
14
NTDs
14
Conflict
14
Ebola & Marburg
13
Health Financing Toolbox
13
Specific Hazards
10
NCDs
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
Zika
2
Social Ethics
1
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
The aim of the Annual Inspection Report is to present findings of public sector health establishments inspected by the OHSC to monitor compliance with the National Core Standards (NCS) during the 2016/2017 financial year in South Africa.
The NCS define fundamentals for quality of care based on six ...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
